Brief: Biosergen Safety Committee Approves To Dose Escalation In Bsg005 Clinical Trial

Biosergen AB

07/11/2024 07:36

Nov 7 (Reuters) - Biosergen AB  BIOSGN.ST :
    * SAFETY COMMITTEE APPROVES TO PROCEED WITH DOSE ESCALATION
IN
SECOND COHORT FOR BSG005 CLINICAL TRIAL

Source text:  ID:nWkr8qkGmY 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))